Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.955
+0.095 (5.11%)
Jun 3, 2026, 2:47 PM EDT - Market open
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $327.31 million as of June 3, 2026. Its market cap has increased by 9,837.74% in one year.
Market Cap
327.31M
Enterprise Value
189.66M
1-Year Change
9,837.74%
Ranking
Category
Stock Price
$1.96
Market Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $327.31M, an increase of 336.02%. That is a compound annual growth rate of 33.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 311.41M | -11.07% |
| Dec 31, 2025 | 350.16M | 7,572.39% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
| Apr 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Larimar Therapeutics | 366.38M |
| Artiva Biotherapeutics | 362.47M |
| Puma Biotechnology | 362.40M |
| Invivyd | 359.42M |
| Conexeu Sciences | 356.81M |
| Nautilus Biotechnology | 352.01M |
| Atea Pharmaceuticals | 350.52M |
| Fennec Pharmaceuticals | 343.20M |